California Cryobank-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:California Cryobank - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011857
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
California Cryobank (CCB) is a healthcare service provider that offers reproductive, stem cell and donor selection services. The center offers services such as donor semen, pricing, donor information subscriptions, graduate donors, donor information, consultation services, genetic services, CCB family services, report pregnancy, sibling registry, directed donor, family-cord, semen, embryo, egg storage, andrology and international shipping services. Its genetic services include donor profile extension, specialty testing and medical issue management services. CCB also offers an online search engine that helps to browse sperm donor catalog by any combination of height, weight, ethnicity, eye or hair color, education, blood type, or even religion from the privacy of one’s own home. The center has its presence in Los Angeles, Los Altos, Cambridge, New York and Houston. CCB is headquartered in Los Angeles, California, the US.

California Cryobank – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
California Cryobank, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
California Cryobank, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
California Cryobank, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
California Cryobank, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
California Cryobank, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
California Cryobank, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Longitude Venture and NovaQuest Pharma Acquire California Cryobank 10
Acquisition 11
California Cryobank Stem Cell Services Acquires Southern Cord 11
California Cryobank Stem Cell Services Acquires LifeLine Cryogenics 12
California Cryobank – Key Competitors 13
California Cryobank – Key Employees 14
California Cryobank – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Other Significant Developments 16
Oct 24, 2017: California Cryobank Introduces the Industry’s Most Thoroughly Screened Sperm Donors Through Their DNA Advantage Program 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
California Cryobank, Pharmaceuticals & Healthcare, Key Facts 2
California Cryobank, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
California Cryobank, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
California Cryobank, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
California Cryobank, Deals By Therapy Area, 2011 to YTD 2017 8
California Cryobank, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Longitude Venture and NovaQuest Pharma Acquire California Cryobank 10
California Cryobank Stem Cell Services Acquires Southern Cord 11
California Cryobank Stem Cell Services Acquires LifeLine Cryogenics 12
California Cryobank, Key Competitors 13
California Cryobank, Key Employees 14
California Cryobank, Other Locations 15
California Cryobank, Subsidiaries 15

★海外企業調査レポート[California Cryobank-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Uni-Select Inc.:企業のM&A・事業提携・投資動向
    Uni-Select Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Uni-Select Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Amryt Pharma plc (AMYT):製薬・医療:M&Aディール及び事業提携情報
    Summary Amryt Pharma plc (Amryt) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for patients with rare and orphan diseases. It has two marketed products include Lojuxta for the treatment of adult HoFH and Episalvan for the treatment of PTW. The …
  • Evonik Industries Ag:企業の戦略・SWOT・財務分析
    Evonik Industries Ag - Strategy, SWOT and Corporate Finance Report Summary Evonik Industries Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bayer Healthcare Pharmaceuticals:企業の戦略・SWOT・財務情報
    Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report Summary Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Symphony Ltd:企業の戦略・SWOT・財務情報
    Symphony Ltd - Strategy, SWOT and Corporate Finance Report Summary Symphony Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • American CryoStem Corp (CRYO):企業の財務・戦略的SWOT分析
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • Maritz Holdings Inc.:企業の戦略的SWOT分析
    Maritz Holdings Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Standard Chem & Pharm Co Ltd:企業の戦略・SWOT・財務分析
    Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Botswana Power Corp:企業の戦略的SWOT分析
    Botswana Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Pharming Group NV (PHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharming Group NV (Pharming) is a specialty pharmaceutical company which develops nutritional products for the treatment of genetic diseases and unmet medical needs. The company’s flagship product, Ruconest (Rhucin in non-European territories) is a recombinant human C1 inhibitor approved for …
  • SR Technics Holding:企業の戦略的SWOT分析
    SR Technics Holding - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • PT Lotte Chemical Titan Tbk:企業の戦略・SWOT・財務情報
    PT Lotte Chemical Titan Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Lotte Chemical Titan Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Agricultural Bank of China Ltd:戦略・SWOT・企業財務分析
    Agricultural Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Agricultural Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Auris Medical Holding AG (EARS):製薬・医療:M&Aディール及び事業提携情報
    Summary Auris Medical Holding AG (Auris Medical) is a clinical-stage biopharmaceutical company with focus on neurotology and mental health supportive care. The company’s pipeline product candidates are in various clinical phases intended for the treatment of acute inner ear tinnitus, post-acute inne …
  • Student Transportation Inc.:企業の戦略・SWOT・財務分析
    Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report Summary Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Crocs Inc (CROX):企業の財務・戦略的SWOT分析
    Crocs Inc (CROX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Doxa AB (DOXA):医療機器:M&Aディール及び事業提携情報
    Summary Doxa AB (Doxa) is a medical device company that develops, manufactures and markets dental bioceramic products. The company’s product includes ceramir crown and bridge, which is dental cement for permanent fixtures including ceramic structures with aluminum oxide or zirconia bodies. Its bioma …
  • University of Helsinki:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Helsinki (UOH) is an educational service provider that offers research and graduate programs. The university operates through independent institutes and faculties for theology, law, medicine, arts, science, pharmacy, biological and environmental sciences, behavioral sciences, s …
  • Antisense Therapeutics Ltd (ANP):企業の財務・戦略的SWOT分析
    Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆